Nevirapine: pharmacokinetic considerations in children and pregnant women.

Abstract

Nevirapine is a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase. It is effective when used as part of combination therapy to treat HIV-1-infected individuals and as monotherapy for prevention of mother-to-child HIV-1 transmission. Nevirapine pharmacokinetics are characterised by rapid absorption and distribution, followed by prolonged… (More)

Topics

Cite this paper

@article{Mirochnick2000NevirapinePC, title={Nevirapine: pharmacokinetic considerations in children and pregnant women.}, author={Mark H Mirochnick and Dave Clarke and Alex Dorenbaum}, journal={Clinical pharmacokinetics}, year={2000}, volume={39 4}, pages={281-93} }